South African tycoon Gus Attridge gains $7.95 million from Aspen shares
The latest bump in his fortune comes on the heels of previous gains between Feb. 12 and March 24, when his stake in Aspen grew by R447.12 million ($25.12 million).
Gus Attridge
South African tycoon Gus Attridge’s stake in Africa’s biggest pharma company hits $215 million
Attridge’s recent financial triumph is attributed to the recent surge in Aspen Pharmacare’s shares on the Johannesburg Stock Exchange (JSE).
South African tycoon Gus Attridge suffers $8-million loss from Aspen shares
Attridge, Aspen’s group chief advisor who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharmaceutical holding company.
South African tycoon Gus Attridge gains nearly $8 million in 16 days
Attridge, Aspen’s group chief advisor who ranks as one of JSE’s richest investors, owns a 4.26-percent stake in the pharma group.
South African tycoon Gus Attridge rakes in $19 million from Aspen shares
The upswing comes on the heels of a setback that led to Attridge recording a loss of $11.96 million between Oct. 2 and Oct. 26.
5 companies owned by South African businessman Gus Attridge
At the helm of Aspen Pharmacare, Attridge has made significant contributions to Africa’s healthcare sector.
South African businessman Gus Attridge earns $1.3-million salary from Aspen
Apart from his executive and governance roles in Aspen Pharmacare, Attridge owns a notable 4.28-percent stake in Aspen.
South African businessman Gus Attridge loses $11.96 million in 24 days
Attridge, Aspen’s group chief advisor, who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharmaceutical holding company.
South African tycoon Gus Attridge loses $7.2 million in 5 days from Aspen stake
Attridge, Aspen’s group chief advisor, who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharmaceutical holding company.
South African executive Gus Attridge loses $27.3 million in 43 days
Attridge, Aspen’s group chief advisor, owns a 4.26-percent stake in the pharmaceutical company.
South African executive scores big with $55-million gain from Aspen Pharmacare
South African executive Michael Guy Attridge (Gus Attridge) has witnessed a remarkable year-to-date gain of more than $55 million from his stake in Aspen Pharmacare
Gus Attridge gains $55 million from investment in Aspen
Attridge, Aspen’s group chief advisor who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharma company.
South African exec Gus Attridge loses $10 million in 13 days from stake in Aspen Pharmacare
Attridge owns a 4.26-percent stake in the company.
South African multimillionaire Gus Attridge’s stake in Aspen now worth $171 million
Aspen Pharmacare is a multinational pharmaceutical holding company.